Boiron is Pharmaceuticals in France that focus on nonproprietary medicines business. Founded in 1932. They cover business area such as Boiron, homeopathic product, its nonproprietary homeopathic medicine, the-counter, generic product, any therapeutic indication, first-resort product, tablet form, drop, syrup, ointment, geographical segment, France, Europe, North America, revenue, Oscillococcinum, stodal, Stodaline, Arnigel, Camilia, Sedatif pc, Coryzalia, Homeoptic, Homeovox.
1932
( 92 years old in 2024 )
Nonproprietary Medicines
-
2, avenue de l'Ouest Lyonnais
69510 Messimy
France
Private
Boironhomeopathic productits nonproprietary homeopathic medicinethe-countergeneric productany therapeutic indicationfirst-resort producttablet formdropsyrupointmentgeographical segmentFranceEuropeNorth AmericarevenueOscillococcinumstodalStodalineArnigelCamiliaSedatif pcCoryzaliaHomeopticHomeovox
* We use standard office opening hours in near Boiron's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Boiron is Pharmaceuticals business from France that founded in 1932 (92 years old in 2024), Boiron business is focusing on Nonproprietary Medicines.
Boiron headquarter office and corporate office address is located in 2, avenue de l'Ouest Lyonnais 69510 Messimy France.
Boiron was founded in France.
In 2024, Boiron is currently focus on nonproprietary medicines sector.
Above is snippet of Google Trends for "nonproprietary medicines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Boiron, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
